XWPharma: Clinical Trials

3 trials sponsored by XWPharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Phase 11Completed 1
Phase 21Withdrawn 1

Follow XWPharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study
Valiloxybate, Placebo - Parkinson Disease, Excessive Daytime Somnolence
Phase 2WithdrawnXWPharma2021-11-012025-03-19
Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults
XW10508, Placebo - Healthy Volunteers
Phase 1CompletedXWPharma842021-07-132022-11-04
Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers
XW10172 - Healthy
Early Phase 1CompletedXWPharma462020-11-292022-11-04

Conditions studied

Disorders of Excessive Somnolence (1)  ·  Parkinson Disease (1)

Countries

Australia (2)

Top investigators

Daniel M. Canafax, PharmD (2)  ·  Daniel M Canafax, PharmD (1)